Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 533-536

  Nash, Kevin A ^a,b   Gaytan, Alfred ^a   Inderlied, Clark B ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0030853904     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517283     Document Type: Article

References (14)

1. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
2. Inderlied CB, Nash KA. Antimycobacterial agents: in vitro susceptibility, mechanisms of action and resistance, and assays for activity in biological fluids. In: Lorian V, ed. Antibiotics in laboratory medicine. 4th ed. Baltimore: Williams & Wilkins, 1996.
3. Heym B, Alzari PM, Honore N, Cole ST. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 1995;15:235-45.
4. Wilson TM, de Lisle GW, Collins DM. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 1995;15:1009-15.
5. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampin resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-50.
6. Kapur V, Ling-Ling LI, Lordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoβ) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York and Texas. J Clin Microbiol 1994;32:1095-8.
7. Williams DL, Waguespack C, Eisenach K, et al. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994;38:2380-6.
8. Nash KA, Inderlied CB. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob Agents Chemother 1996;40:1748-50.
9. Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JYH. NIRCA: A rapid robust method for screening for unknown point mutations. Biotechniques 1996;21:106.
10. Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995;39:2625-30.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
12. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility tests: mycobacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:1385-404.
13. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Centers for Disease Control, 1985.
14. De-Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 1995;76:425-30.